Schedule of Conference Call to discuss financial performance for quarter and financial year ended March 31, 2026
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Ltd has scheduled an earnings conference call for Friday, May 22, 2026 at 12:30 PM IST to discuss its Q4 and FY26 financial results (quarter and financial year ended March 31, 2026). The call will be attended by Managing Director Mr. Hitesh Windlass and CEO & CFO Ms. Komal Gupta. The company disclosed this schedule to BSE and NSE in compliance with SEBI Listing Regulations. This is a routine earnings call announcement common for listed companies to provide analysts and investors an opportunity to interact with management after results are declared.
This is a standard scheduled event; retail investors can participate in the earnings call to gain clarity on the company's Q4 and full-year performance. No immediate price impact, but the management commentary may influence sentiment post-call.